Cuiling Zhang
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A Dual-Membrane Biomimetic Nanoplatform Enables Triple-Modal Therapy Against SARS-CoV-2 Through Viral Decoy, Inflammation Neutralizing, and Intracellular RNAi.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 02, 2026
Copper-based drugs inhibit infectious bronchitis virus (IBV) in vitro and in vivo.
Journal: Veterinary microbiology
Published: September 15, 2025
NQO1-responsive Trimethyl lock benzoquinone: A cleavable linker strategy for antibody-drug conjugates.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 04, 2025
Broad-spectrum antiviral activity of the sigma-1 receptor antagonist PB28 against coronaviruses.
Journal: Frontiers in microbiology
Published: May 27, 2025
Clinical manifestations and pathogenicity of Clade IIb monkeypox virus in rabbits.
Journal: Emerging microbes & infections
Published: February 13, 2025
SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor.
Journal: Journal of virology
Published: October 24, 2024
Establishment of an animal model for monkeypox virus infection in dormice.
Journal: Scientific reports
Published: October 10, 2024
Infectious bronchitis virus (IBV) triggers autophagy to enhance viral replication by activating the VPS34 complex.
Journal: Microbial pathogenesis
Published: November 28, 2023
Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model.
Journal: Virology journal
Published: June 28, 2022
SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment.
Journal: Frontiers in microbiology
Published: September 21, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026